We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$404M
AUM Growth
-$193M
Cap. Flow
-$235M
Cap. Flow %
-58.22%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$13M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$118M
2
VGK icon
Vanguard FTSE Europe ETF
VGK
+$102M
3
WMGI
Wright Medical Group Inc
WMGI
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$655B
$261M 64.67%
2,979,100
-1,362,900
-31% -$118M
VGK icon
2
Vanguard FTSE Europe ETF
VGK
$30.1B
$115M 28.36%
2,101,000
-1,942,000
-48% -$102M
WMGI
3
DELISTED
Wright Medical Group Inc
WMGI
$15.3M 3.78%
585,759
-585,760
-50% -$15.3M
PTCT icon
4
PTC Therapeutics
PTCT
$6.29B
$11.2M 2.78%
+747,359
New +$13M

Similar funds

HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Novo Holdings A/S's Q3 2013 Portfolio in Review

As of Q3 2013, Novo Holdings A/S held 5 positions worth $404M, down 32% from $597M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Novo Holdings A/S withdrew a net $235M in Q3 2013, reducing 3 holdings. Its largest reduction was Vanguard Total Stock Market ETF, cutting an estimated $118M.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.1% a quarter earlier.

Against the trend, Novo Holdings A/S opened a new position in PTC Therapeutics worth $11.2M.

  • Novo Holdings A/S's largest Q3 2013 buy was PTC Therapeutics: 747,359 shares worth $11.2M.
  • Novo Holdings A/S's biggest Q3 2013 reduction was Vanguard Total Stock Market ETF, cutting an estimated $118M.
  • Novo Holdings A/S's ten largest holdings make up 100% of its $404M portfolio in Q3 2013.
  • Novo Holdings A/S opened 1 new position and closed 0 in Q3 2013.
  • Novo Holdings A/S's portfolio value fell 32% quarter-over-quarter to $404M.

Based on Novo Holdings A/S's 13F filing for Q3 2013, filed 14 Nov 2014.